THIQ was synthesized as a peptidomimetic of the potent α-MSH analog MT-II as a potential treatment for obesity [36] and is approximately 30-fold more potent at MC4R than α-MSH (Fig. 3 and Table 1). The gene discussed is MC4R; the disease is obesity disorder.